Citius Oncology (CTOR) Institutional Ownership $1.80 -0.01 (-0.55%) As of 02:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Citius Oncology (NASDAQ:CTOR)CurrentInstitutional OwnershipPercentage70.52%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$754.85KNumber ofInstitutional Sellers(last 12 months)0 Get CTOR Insider Trade Alerts Want to know when executives and insiders are buying or selling Citius Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CTOR Institutional Buying and Selling by Quarter Citius Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bank of America Corp DE8,571$37K0.0%+5,256.9%0.011% 8/14/2025 Jane Street Group LLC106,970$465K0.0%N/A0.136% 8/8/2025 Geode Capital Management LLC57,297$249K0.0%+179.0%0.073% 8/4/2025 Arkadios Wealth Advisors11,666$51K0.0%N/A0.015% 2/17/2025Citadel Advisors LLC22,699$26K0.0%N/A0.032% 2/4/2025IFP Advisors Inc22,215$26K0.0%+173.1%0.031% (Data available from 1/1/2016 forward) CTOR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTOR shares? During the previous two years, the following institutional investors and hedge funds held shares of Citius Oncology shares: Jane Street Group LLC ($465K), Geode Capital Management LLC ($249K), Arkadios Wealth Advisors ($51K), Bank of America Corp DE ($37K), and Citadel Advisors LLC ($26K), IFP Advisors Inc ($26K).Learn more on Citius Oncology's institutional investors. What percentage of Citius Oncology's stock is owned by institutional investors? 70.52% of Citius Oncology's stock is owned by institutional investors. Learn more on CTOR's institutional investor holdings. Which institutional investors have been buying Citius Oncology's stock? The following institutional investors have purchased Citius Oncology's stock in the last 24 months: Jane Street Group LLC ($106.97K), Geode Capital Management LLC ($36.76K), Citadel Advisors LLC ($22.70K), IFP Advisors Inc ($14.08K), Arkadios Wealth Advisors ($11.67K), and Bank of America Corp DE ($8.41K). How much institutional buying is happening at Citius Oncology? Institutional investors have bought a total of 200,584 shares in the last 24 months. This purchase volume represents approximately $754.85K in transactions. Related Companies Savara Institutional Ownership AnaptysBio Institutional Ownership Olema Pharmaceuticals Institutional Ownership Opthea Institutional Ownership Bicara Therapeutics Institutional Ownership Arcturus Therapeutics Institutional Ownership Arvinas Institutional Ownership Aquestive Therapeutics Institutional Ownership Inventiva Institutional Ownership Erasca Institutional Ownership This page (NASDAQ:CTOR) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTOR Stock Alerts